NT5E and head and neck carcinoma: In contrast, NT5E, or CD73, has been widely implicated in cancer as an adenosine-generating immune checkpoint (60), expressed on cancer-associated fibroblasts with a controversial role: a negative prognostic factor in head and neck carcinoma (61) and colorectal cancer (60), but a positive prognostic factor in lung and gastric cancers (62).